NCT03962543 2026-04-08ReNeuSpringWorks Therapeutics, Inc.Phase 2 Active not recruiting114 enrolled 25 charts 3 FDA
NCT03873610 2025-12-26Resiliency Training in Adolescents With NF1 and NF2Massachusetts General HospitalPhase NA Active not recruiting200 enrolled